Rasik Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.15 Cr
as on 16-11-2024
- Revenue 14.94%
(FY 2023)
- Profit -39.52%
(FY 2023)
- Ebitda 66.47%
(FY 2023)
- Net Worth 26.83%
(FY 2023)
- Total Assets 4.84%
(FY 2023)
About Rasik Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹11.15 Cr.
Gaurav Khandelwal, Keshav Khandelwal, Swati Khandelwal, and Five other members serve as directors at the Company.
- CIN/LLPIN
U51397RJ2009PTC029310
- Company No.
029310
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Ajmer, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rasik Remedies?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Khandelwal  | Director | 07-Jul-2009 | Current |
| Keshav Khandelwal | Director | 22-Dec-2018 | Current |
| Swati Khandelwal | Director | 22-Dec-2018 | Current |
| Poonam Khandelwal | Director | 22-Dec-2018 | Current |
| Kali Khandelwal | Director | 22-Dec-2018 | Current |
| Saroj Khandelwal | Director | 22-Dec-2018 | Current |
Financial Performance of Rasik Remedies.
Rasik Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.94% increase. The company also saw a substantial fall in profitability, with a 39.52% decrease in profit. The company's net worth Soared by an impressive increase of 26.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rasik Remedies?
In 2023, Rasik Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Safpure Lifesciences Private LimitedActive 11 years 8 monthsGaurav Khandelwal, Kali Khandelwal and 1 more are mutual person
- Shri Shyam Prime Commodities Private LimitedActive 12 years 8 months
Gaurav Khandelwal, Keshav Khandelwal and 1 more are mutual person
- Rex Remedies Distributors Private LimitedActive 7 years 4 months
Kali Khandelwal, Saroj Khandelwal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Apr 2024 | ₹1.50 M | Open |
Others Creation Date: 31 Jan 2023 | ₹1.00 M | Open |
Hdfc Bank Limited Creation Date: 03 Jul 2018 | ₹10.90 Cr | Open |
How Many Employees Work at Rasik Remedies?
Rasik Remedies has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rasik Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rasik Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
